About FDA
Carryover Balances: FY 2011 ADUFA Financial Report
Back to Table of Contents: FY 2011 ADUFA Financial Report
Under ADUFA, fees collected, appropriated, and not obligated at the end of a fiscal year remain available to the FDA for use in future fiscal years. These funds are referred to as carryover balances. The operations in FY 2011 resulted in a net increase of the carryover balance of $1,435,856, resulting in a year-end carryover balance of $4,664,293.
Table 3 captures FDA’s carryover balances at the beginning of each fiscal year since the enactment of ADUFA in 2003.
Table 3
Animal Drug User Fee Collections,
Obligations, And Carryover Balances By Fiscal Year
FISCAL BEGINNING NET COLLECTION OBLIGATIONS YEAR-END CARRYOVER 2004 - $4,866,475 $1,083,300 $3,783,175 2005 $3,783,175 $8,301,551 $8,489,000 $3,595,726 2006 $3,595,726 $11,017,828 $9,675,678 $4,937,876 2007 $4,937,876 $13,471,861 $12,270,000 $6,139,736 2008 $6,139,736 $11,420,145 $13,530,069 $4,029,812 2009 $4,029,812 $13,363,223 $13,379,200 $4,013,835 2010 $4,013,835 $15,815,302 $16,600,700 $3,228,437 2011 $3,228,437 $18,068,656 $16,632,800 $4,664,293 2012 $4,664,293
Numbers may not total precisely due to rounding to the nearest dollar.
Please note the balances in Table 3 reflect the cumulative cash from the beginning to the end of each fiscal year, the net cash collected, and any refunds or other adjustments that occurred during each fiscal year for all cohort years. The numbers do not include any accounts receivable. Therefore, these numbers for FY 2010 and FY 2011 are different from the numbers in Table 1, which reflect total net collections for the cohort years only.
